{"id":"third-generation-cephalosporins","safety":{"commonSideEffects":[{"rate":"5-15","effect":"Diarrhea"},{"rate":"2-10","effect":"Nausea"},{"rate":"1-5","effect":"Vomiting"},{"rate":"1-3","effect":"Rash"},{"rate":"1-3","effect":"Hypersensitivity reactions"},{"rate":"<1","effect":"Pseudomembranous colitis"},{"rate":"1-3","effect":"Elevated liver enzymes"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"These beta-lactam antibiotics penetrate the bacterial cell wall and covalently bind to penicillin-binding proteins, preventing the cross-linking of peptidoglycan strands essential for cell wall integrity. This leads to cell wall weakening, osmotic instability, and bacterial cell lysis. Third-generation cephalosporins have enhanced activity against gram-negative organisms and improved beta-lactamase stability compared to earlier generations.","oneSentence":"Third-generation cephalosporins inhibit bacterial cell wall synthesis by binding to penicillin-binding proteins and blocking cross-linking of peptidoglycan.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:12:27.879Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Bacterial infections caused by susceptible gram-positive and gram-negative organisms"},{"name":"Respiratory tract infections"},{"name":"Urinary tract infections"},{"name":"Intra-abdominal infections"},{"name":"Meningitis"},{"name":"Sepsis"}]},"trialDetails":[{"nctId":"NCT01485029","phase":"NA","title":"Streptococcus Pneumoniae Nasopharyngeal Carriage","status":"COMPLETED","sponsor":"Department of Clinical Research and Innovation","startDate":"2012-01-01","conditions":"Nursery","enrollment":500},{"nctId":"NCT07442357","phase":"NA","title":"The Per-procedural Antibiotic Prophylaxis in Patients Undergoing Transcatheter Aortic Valve Implantation Trial","status":"NOT_YET_RECRUITING","sponsor":"Rigshospitalet, Denmark","startDate":"2026-06-01","conditions":"Aortic Valve Stenosis","enrollment":1986},{"nctId":"NCT07403032","phase":"NA","title":"Study on the Effects and Mechanisms of Modified Ma Xing Shi Gan Decoction in Treating Acute Exacerbations of Chronic Obstructive Pulmonary Disease","status":"NOT_YET_RECRUITING","sponsor":"Cuiling Feng","startDate":"2026-01-12","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":200},{"nctId":"NCT07399717","phase":"NA","title":"Assessing Role of Probiotics in Children Aged 6-36 Months Treated for Pneumonia","status":"NOT_YET_RECRUITING","sponsor":"Anabio R&D","startDate":"2026-01-26","conditions":"Pneumonia, Pneumonia in Children","enrollment":330},{"nctId":"NCT04478721","phase":"PHASE3","title":"Temocillin vs Meropenem for the Targeted Treatment of Bacteraemia Resistant to Third Gen Cephalosporins","status":"COMPLETED","sponsor":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","startDate":"2020-12-15","conditions":"Bacteremia","enrollment":334},{"nctId":"NCT06294600","phase":"PHASE3","title":"Clarithromycin Treatment to Prevent Sepsis Progression in CAP (REACT)","status":"RECRUITING","sponsor":"Hellenic Institute for the Study of Sepsis","startDate":"2024-02-12","conditions":"Community-acquired Pneumonia","enrollment":330},{"nctId":"NCT07196475","phase":"NA","title":"Transurethral Focal Laser Ablation Versus Transurethral Prostatectomy For Management Of Benign Prostatic Obstruction","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2021-06-01","conditions":"Benign Prostate Hypertrophy(BPH)","enrollment":56},{"nctId":"NCT02996656","phase":"NA","title":"Antimicrobial Prophylaxis for Skin Colonization With Propionibacterium Acnes in Primary Open Shoulder Surgery","status":"RECRUITING","sponsor":"Université de Montréal","startDate":"2016-12","conditions":"Propionibacterium Infection","enrollment":88},{"nctId":"NCT06875518","phase":"NA","title":"Comparative Study of Blood Loss in Total Laparoscopic Hysterectomy by Ligation the Uterine Arteries in Different Techniques.","status":"RECRUITING","sponsor":"Mostafa Bahaa","startDate":"2025-03-12","conditions":"Gynecologic Disease","enrollment":60},{"nctId":"NCT06517264","phase":"NA","title":"Effectiveness and Safety of Outpatient Treatment of Uncomplicated Acute Diverticulitis Without Antibiotics","status":"ENROLLING_BY_INVITATION","sponsor":"Monica Mengual Ballester","startDate":"2024-11-01","conditions":"Diverticulitis, Colonic","enrollment":282},{"nctId":"NCT04140903","phase":"PHASE4","title":"Partial Oral Antibiotic Treatment for Bacterial Brain Abscess","status":"RECRUITING","sponsor":"Henrik Nielsen","startDate":"2020-11-06","conditions":"Brain Abscess, Cerebral Abscess","enrollment":400},{"nctId":"NCT06572761","phase":"PHASE3","title":"A Combination of Antibiotics to Decrease Neonatal Morbidity and Mortality for Previable Threatened Labor","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-09","conditions":"Previable Labour With Intact Membranes","enrollment":350},{"nctId":"NCT04041791","phase":"PHASE3","title":"A Study to Compare Different Antibiotics and Different Modes of Fluid Treatment for Children With Severe Pneumonia","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2019-08-19","conditions":"Pneumonia","enrollment":4392},{"nctId":"NCT05880069","phase":"","title":"Clinical Outcomes in Patients With Infection by Resistant Microorganism","status":"UNKNOWN","sponsor":"Hospital Universitario Virgen Macarena","startDate":"2022-10-01","conditions":"Pneumonia, Bloodstream Infection, Urinary Tract Infections","enrollment":5000},{"nctId":"NCT05398081","phase":"PHASE2","title":"Cefuroxime vs Ceftriaxone for SSI Prevention in Neurosurgery","status":"COMPLETED","sponsor":"Dr. Promise Tamunoipiriala Jaja","startDate":"2021-12-01","conditions":"Surgical Site Infection, Antibiotics Prophylaxis","enrollment":96},{"nctId":"NCT03439124","phase":"PHASE3","title":"Ceftobiprole in the Treatment of Pediatric Patients With Pneumonia","status":"COMPLETED","sponsor":"Basilea Pharmaceutica","startDate":"2017-11-27","conditions":"Community-acquired Pneumonia (CAP), Hospital-acquired Pneumonia (HAP)","enrollment":138},{"nctId":"NCT03925402","phase":"","title":"Ertapenem for Initial Empirical Treatment of Third Generation Cephalosporin Resistant Enterobacteriaceae Bacteremia","status":"COMPLETED","sponsor":"Phramongkutklao College of Medicine and Hospital","startDate":"2019-05-15","conditions":"Bacteremia, Infection, Bacterial","enrollment":427},{"nctId":"NCT05413772","phase":"","title":"Temocillin in ESBL-Enterobacteriaceae Infections","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2022-10-20","conditions":"Infectious Disease","enrollment":29},{"nctId":"NCT04711122","phase":"","title":"Prophylactic Antibiotics in Prevention of Spontaneous Bacterial Peritonitis in Compensated Liver Cirrhosis","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2022-12-01","conditions":"Liver Cirrhosis, Upper Gastrointestinal Bleeding","enrollment":80},{"nctId":"NCT05464303","phase":"","title":"Definition for Biliary Atresia Associated Cholangitis After Surgery","status":"UNKNOWN","sponsor":"Nanjing Children's Hospital","startDate":"2022-07-15","conditions":"Biliary Atresia, Cholangitis","enrollment":500},{"nctId":"NCT03765749","phase":"","title":"Empirical Antibiotic and Outcome in Community-onset Bacteremia","status":"COMPLETED","sponsor":"Phramongkutklao College of Medicine and Hospital","startDate":"2018-11-22","conditions":"Bacteremia","enrollment":108},{"nctId":"NCT04479228","phase":"NA","title":"Plastic Stents vs. NAGI Bi-flanged Metal Stent for Endoscopic Ultrasound Guided Drainage of Walled-off Necrosis","status":"UNKNOWN","sponsor":"Asian Institute of Gastroenterology, India","startDate":"2020-08-01","conditions":"Acute Necrotizing Pancreatitis, Walled Off Necrosis","enrollment":80},{"nctId":"NCT03174236","phase":"PHASE3","title":"First Line Antimicrobials in Children With Complicated Severe Acute Malnutrition","status":"UNKNOWN","sponsor":"University of Oxford","startDate":"2017-09-04","conditions":"Malnutrition Severe, Antibiotic Resistance, Antibiotic Toxicity","enrollment":2000},{"nctId":"NCT04363060","phase":"PHASE3","title":"Azithromycin+Amoxicillin/Clavulanate vs Amoxicillin/Clavulanate in COVID19 Patients With Pneumonia in Non-intensive Unit","status":"UNKNOWN","sponsor":"Nantes University Hospital","startDate":"2020-04-30","conditions":"COVID-19 Pneumonia","enrollment":104},{"nctId":"NCT03922919","phase":"PHASE4","title":"Effect of Administration of 3rd Generation Cephalosporin on the Digestive Carrying of 3rd Generation Cephalosporin-resistant Enterobacteriaceae (CEF-IMPACT)","status":"UNKNOWN","sponsor":"Centre Hospitalier Universitaire de Besancon","startDate":"2018-04-03","conditions":"Infectious Disease - Resistant Enterobacteriaceae (Diagnosis)","enrollment":250},{"nctId":"NCT03226314","phase":"","title":"Community Epidemiology and Typology of Third-generation Cephalosporins Resistant Enterobacteriaceae in Reunion Island","status":"UNKNOWN","sponsor":"Centre Hospitalier Universitaire de la Réunion","startDate":"2017-11-21","conditions":"Bacterial Resistance","enrollment":500},{"nctId":"NCT02515565","phase":"NA","title":"Physiotherapy in Patients Hospitalized Due to Pneumonia.","status":"UNKNOWN","sponsor":"Universidad de Granada","startDate":"2015-09","conditions":"Pneumonia","enrollment":60},{"nctId":"NCT02659033","phase":"PHASE3","title":"Impact of the Choice of 3rd Generation Cephalosporins on the Emergence of Resistance in the Microbiota Intestinal.","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2016-03","conditions":"Emergence of Bacterial Resistance to Antibiotics","enrollment":22},{"nctId":"NCT03266380","phase":"","title":"Risk Factors and Common Preventive Measures for Ventilator Associated Pneumonia in Patients With Severe Traumatic Brain Injury","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2018-01-01","conditions":"Ventilator Associated Pneumonia","enrollment":80},{"nctId":"NCT02443285","phase":"PHASE3","title":"Is Spontaneous Bacterial Peritonitis Still Responding to 3rd Generation Cephalosporins?","status":"UNKNOWN","sponsor":"Tanta University","startDate":"2015-01","conditions":"Primary Bacterial Peritonitis","enrollment":100},{"nctId":"NCT02314013","phase":"NA","title":"Randomized Clinical Trial for the Uncomplicated Diverticulitis in Right Colon","status":"UNKNOWN","sponsor":"Dongtan Sacred Heart Hospital","startDate":"2014-04","conditions":"Simple Diverticular Disease","enrollment":132},{"nctId":"NCT00488189","phase":"PHASE4","title":"Study Evaluation Tazocin Intervention","status":"COMPLETED","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","startDate":"2007-05","conditions":"Bacterial Infections","enrollment":134},{"nctId":"NCT01189955","phase":"NA","title":"the Use of Harmonic Scalpel Versus Knot Tying for Total Thyroidectomy","status":"COMPLETED","sponsor":"Mansoura University","startDate":"2008-02","conditions":"Thyroid Swelling","enrollment":130},{"nctId":"NCT00488813","phase":"PHASE4","title":"Study of Antibiotic Utilization Measures and Control of ESBLs in China","status":"COMPLETED","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","startDate":"2004-07","conditions":"ICU Patient","enrollment":300},{"nctId":"NCT00886210","phase":"NA","title":"Clinical Impact of Routine Abdominal Drainage After Laparoscopic Cholecystectomy","status":"COMPLETED","sponsor":"Mansoura University","startDate":"2006-10","conditions":"Abdominal Drainage, Laparoscopic Cholecystectomy, Gall Stones","enrollment":100}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":4227,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Third generation cephalosporins","genericName":"Third generation cephalosporins","companyName":"Wyeth is now a wholly owned subsidiary of Pfizer","companyId":"wyeth-is-now-a-wholly-owned-subsidiary-of-pfizer","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Third-generation cephalosporins inhibit bacterial cell wall synthesis by binding to penicillin-binding proteins and blocking cross-linking of peptidoglycan. Used for Bacterial infections caused by susceptible gram-positive and gram-negative organisms, Respiratory tract infections, Urinary tract infections.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}